Advertisement
Product › Details
cinrebafusp alfa (PRS-343)
Next higher product group | cancer drug_o | |
Status | 2023-04-17 development pc existent | |
Organisation | Pieris Pharmaceuticals Inc. (Nasdaq: PIRS) | |
Group | Pieris (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for cinrebafusp alfa (PRS-343)
- [1] Pieris Pharmaceuticals, Inc.. (4/17/23). "Press Release: Pieris Pharmaceuticals Announces Presentation of Positive Clinical Data for Cinrebafusp Alpa (PRS-343) At 2023 AACR Annual Meeting". Boston, MA....
- [2] Pieris Pharmaceuticals, Inc.. (8/1/19). "Press Release: Pieris Pharmaceuticals Reports Second Quarter 2019 Cash Position and Provides Corporate Update". Boston, MA....
- [3] Pieris Pharmaceuticals, Inc.. (9/4/18). "Press Release: Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Combination Trial for PRS-343 Plus Anti-PD-L1 Immunotherapy". Boston, MA....
- [4] Pieris Pharmaceuticals, Inc.. (8/9/18). "Press Release: Pieris Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update". Boston, MA....
- [5] Pieris Pharmaceuticals, Inc.. (5/10/18). "Press Release: Pieris Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update". Boston, MA....
- [6] Pieris Pharmaceuticals, Inc.. (3/9/18). "Press Release: Pieris Pharmaceuticals Reports Full-Year 2017 Financial Results and Corporate Update". Boston, MA....
- [7] Pieris Pharmaceuticals, Inc.. (10/12/17). "Press Release: Pieris Pharmaceuticals Appoints Ingmar Bruns, M.D., Ph.D., as Vice President of Clinical Development". Boston, MA....
- [8] Pieris Pharmaceuticals, Inc.. (10/2/17). "Press Release: Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Trial for Fully Proprietary Lead IO Program, PRS-343". Boston, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top